Garuda Therapeutics, Inc. — Form D
Garuda Therapeutics, Inc. of Cambridge, MA, a company, filed a Form D exempt-offering notice with the SEC on 2023-02-03. The offering totals $62.9M, of which $62.1M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-02-03
- Form: D
- Accession: 0001884363-23-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $62.9M
- Amount sold: $62.1M
- Remaining: $773K
- Investors: 13
- Date of first sale: 2023-01-23
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-472601
Issuer
- Name: Garuda Therapeutics, Inc.
- CIK: 0001884363
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 215 First Street, Cambridge, MA, 02142
- Phone: 617-851-4586
Officers, directors & promoters (18)
| Name | Role | Location |
|---|
| Eric I Aguiar | Director | Cambridge, MA |
| Carl I Gordon | Director | Cambridge, MA |
| Daniel I Janse | Director | Cambridge, MA |
| Raymond I Kelleher | Director | Cambridge, MA |
| Laurence I Reid | Director | Cambridge, MA |
| Dhvanit I Shah | Director | Cambridge, MA |
| Rahul I Singhvi | Director | Cambridge, MA |
| Dhvanit I Shah | Executive Officer | Cambridge, MA |
| CARL GORDON | Director | SAN DIEGO, CA |
| Steve Liapis | Director | Cambridge, MA |
| David Kirske | Executive Officer | BOSTON, MA |
| Adam Craig | Director | BOSTON, MA |
| Adam Craig | Executive Officer | BOSTON, MA |
| Raymond Kelleher | Director | South San Francisco, CA |
| Geoff Meyerson | Director | Cambridge, MA |
| Eric Aguiar | Director | Cambridge, MA |
| Rahul Singhvi | Director | Cambridge, MA |
| Shaan I Gandhi | Director | Natick, MA |
Other filings by this issuer (2)
More